Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Hepatitis C treatment in "difficult-to-treat" psychiatric patients with pegylated interferon-alpha and ribavirin: response and psychiatric side effects.

Hepatology (Baltimore, Md.) - 1 Oct 2007

Schaefer Martin, Hinzpeter Axel, Mohmand Ariane, Janssen Gesa, Pich Maurice, Schwaiger Markus, Sarkar Rahul, Friebe Astrid, Heinz Andreas, Kluschke Michael, Ziemer Marlene, Gutsche Juri, Weich Viola, Halangk Juliane, Berg Thomas

Abstract excerpt

UNLABELLED: We investigated and compared the results of treating the chronic hepatitis C (HCV) infection of different groups of psychiatric-risk patients and controls with pegylated interferon alpha (pegIFN-alpha) plus ribavirin. Seventy patients were prospectively screened for psychiatric disorders. Seventeen patients without psychiatric diseases or drug addiction (controls), 22 patients with psychiatric...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antidepressive Agents
Share to Depression

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Interferon-alpha

Share to Interferon alpha-2

Share to Mental Disorders

Share to Polyethylene Glycols

Share to Ribavirin

Share to Substance-Related Disorders

Source

Identifiers

PMID: 17668880
DOI: 10.1002/hep.21791

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Hepatitis C treatment in "difficult-to-treat" psychiatric patients with pegylated interferon-alpha and ribavirin: response and psychiatric side effects.PMID 17668880Read ↗

[Difficult-to-treat patients with chronic hepatitis C].Semantic proximity Read ↗

Factors associated with treatment failure of patients with psychiatric diseases and injecting drug users in the treatment of genotype 2 or 3 hepatitis C chronic infection.Semantic proximity Read ↗

Association between risk factors, basal viral load, virus genotype and the degree of liver fibrosis with the response to the therapy in patients with chronic hepatitis C virus infection.Semantic proximity Read ↗

Psychiatric problems in patients infected with hepatitis C before and during antiviral treatment with interferon-alpha: a review.Semantic proximity Read ↗

Retention rate and side effects in a prospective trial on hepatitis C treatment with pegylated interferon alpha-2a and ribavirin in opioid-dependent patients.Semantic proximity Read ↗

Utilizing genomic polymorphisms to personalize hepatitis C therapies.Semantic proximity Read ↗

The Severity of Depressive Symptoms as an Independent Predictor of Sustained Virological Response During Treatment of Hepatitis C With Pegylated Interferon-α2a and Oral Ribavirin.Semantic proximity Read ↗

Sustained virological response in the antiviral therapy of chronic hepatitis C: is there a predictive value of interferon-induced depression?Semantic proximity Read ↗

Belgian experience with triple therapy with boceprevir and telaprevir in genotype 1 infected patients who inject drugs.Semantic proximity Read ↗

Global Real-World Evidence of Sofosbuvir/Velpatasvir as a Highly Effective Treatment and Elimination Tool in People with Hepatitis C Infection Experiencing Mental Health Disorders.Semantic proximity Read ↗

[Increased prevalence of depression in hepatitis C infection patients].Semantic proximity Read ↗

Treatment of hepatitis C virus infection in people with opioid use disorder: a real-world study of elbasvir/grazoprevir in a US Department of Veterans Affairs population.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.